Mr. D’Arcy has served as a member of the Board of Directors of Premier, Inc. and the Management Committee of Premier Services, LLC since October 2013. Mr. D’Arcy has served as a Partner of Quantum Group LLC, an investment and consulting firm since 2010.

Previously, he worked for Pricewaterhouse-Coopers LLP, a multinational professional services firm, for 34 years, serving most recently as Global Automotive Leader from 2002 to 2010. He served on the Board of Vanguard Health Systems Inc., a company previously listed on the New York Stock Exchange (“NYSE”), from 2011 to 2013.

In addition, he currently serves on the Board of Penske Corporation and the Hudson-Webber Foundation and served as Non Executive Chairman of the Board of Trustees of The Detroit Medical Center from 2006 to 2010. Mr. D’Arcy obtained a bachelor’s degree in Business Administration from the University of Michigan.

Susan DeVore is president and CEO of Premier, Inc., a leading healthcare improvement company. Uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provide organizations to transform healthcare, Premier enables better care and outcomes at a lower cost.

With approximately 30 years of experience, DeVore is an industry-leading thinker who has been named to Modern Healthcare’s 100 Most Influential People in Healthcare and Top 25 Women in Healthcare lists. She serves as chairman of the board trustees of the Healthcare Leadership Council, board member of the Coalition to Protect America’s Healthcare and board member, finance committee member and audit committee chair of the Medicare Rights Center. She also serves as a member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare, as an executive committee member of the Charlotte Chamber of Commerce, on the audit and finance committee for Adventist Health System, and is a member of the Midwest Healthcare Executive Summit.

Under DeVore’s leadership, Premier has been recognized for building an industry-leading code of ethics, has been named eight times as one of the World’s Most Ethical Companies by Ethisphere, won the Malcolm Baldrige National Quality Award and has been named four times to the InformationWeek 500 list of the top technology innovators in the nation.

DeVore obtained a bachelor’s degree from the University of North Carolina at Charlotte and a Master of Management degree from McGill University.

Recognition:

• Modern Healthcare’s 100 Most Influential People in Healthcare in 2004, 2012, 2013, 2014
• Modern Healthcare’s Top 25 Women in Healthcare in 2005, 2013, 2015
• Queens University of Charlotte’s 2014 BusinessWoman of the Year
• Silver Stevie Award for Executive of the Year for Health Products and Services in 2014
• Charlotte Business Journal Women in Business Achievement Award winner in 2014
• Charlotte Business Journal’s top newsmakers of 2009, 2013, 2014
• Charlotte Business Journal’s Who to Watch in 2012
• The Charlotte Observer’s 2011 Seven to Watch
• Named one of Business Leader magazine’s 2010 Business Leaders of the Year
• Honorable mention for 2010 Stevie Award for top executive
• Business Leader magazine’s Women Extraordinaire in 2009
• One of North Carolina’s most influential and dynamic leaders in 2009 by Business Leader magazine
• Recognized by US Airways magazine for significant contributions in Charlotte in 2009
• Charlotte Business Journal’s 2007 Top 25 Women in Business

Peter S. Fine has been a member of Premier’s board of directors since October 2013. He served previously on the board of directors of Premier Healthcare Solutions Inc. from 2003 through 2009.

Since 2000, Fine has served as the President and Chief Executive Officer of Banner Health. He also currently serves as a member of the board of directors of Banner Health. In addition, he previously served on the boards of directors of Accuray Incorporated and the Translational Genomics Research Institute, and as a member of the Heard Museum board of trustees.

Fine received his bachelor’s degree from Ohio University and Master of Arts in healthcare administration from George Washington University.

Mr. Langstaff has served as a member of the Board of Directors of Premier, Inc., since September 2016, and also is a member of the board’s Audit and Compliance and Member Agreement Review committees. Mr. Langstaff has been president of Argotyche, Inc., a consulting and advisory services company, since 2013. He also serves as board chair of Monitor 360, a narrative analytics and strategy company; as proxy board chair of MorphoTrust, a biometric identification company; and as a director of The Hitachi Foundation, Inc., a philanthropic organization.

His prior career includes serving as the president and chief executive officer of TASC Inc., a defense contractor, as well as the founder, president and chief executive officer of Veridian Corporation, a NYSE-listed company specializing in mission-critical national security programs. Mr. Langstaff also served as chief executive officer and co-chairman of The Olive Group, a global integrated security company, from 2006 until 2007.

Mr. Langstaff currently serves on the Defense Business Board, which provides independent advice to the Secretary and Deputy Secretary of Defense, and has been associated with The Aspen Institute since 1998. He earned his bachelor’s degree and MBA from Harvard University.

Marc D. Miller has served as a member of the board of directors of Premier since August 2015. Miller was named CEO of UHS in January 2021 after having served as President since 2009. UHS is a NYSE-listed company headquartered in King of Prussia, Pennsylvania. Prior to his executive position, Miller served in various leadership roles with Universal Health Services, as well as key positions with Central Montgomery Medical Center, Wellington Regional Medical Center, The George Washington University Hospital and Mayo Clinic. He serves on the board of trustees of Universal Health Services and of Universal Health Realty Income Trust, a NYSE-listed company.

Miller received a bachelor’s degree from the University of Vermont and an MBA with a concentration in healthcare management and finance from The Wharton School at the University of Pennsylvania.

Mr. Reiner has served as a member of the Board of Directors of Premier, Inc., since December 2015. Mr. Reiner has been the President and Chief Executive Officer of Adventist Health, the tenth largest nonprofit hospital system in the U.S., since 2014. Adventist Health is one of our member owners and serves communities in California, Hawaii, Oregon and Washington. Mr. Reiner previously served in various executive roles with Adventist Health, including Executive Vice President and Chief Operating Officer from 2011 to 2013 and Senior Vice President from 2007 to 2011. Prior to Adventist Health, he served as President and Chief Executive Officer of Glendale Adventist Medical Center and served in executive positions with General Health System, Tennessee Christian Medical Center and Affiliated Physicians Medical Group.

Mr. Reiner serves on the boards of directors of Adventist Health, California Hospital Association, Loma Linda University Health and Loma Linda University Medical Center and previously served on the board of directors of American Hospital Association Region Nine. He is a registered nurse and received a bachelor’s degree from Pacific Union College, a Masters degree in Health Administration from California State University, Northridge and a Certificate in Managed Care Administration from the University of Missouri.

Richard J. Statuto has been a member of Premier’s board of directors since May 2013 and previously served as the board chair from 2013 to August 2019. He was a member of the board of directors of Premier Healthcare Solutions Inc. and the board of managers of Premier Plans from 2011 to 2013.

From 2005 to September 2018, Statuto served as the President and Chief Executive Officer of Bon Secours Health System and as an advisor to Bon Secours Mercy Health, primarily focused on strategic growth and innovation from September 2018 to August 2019. Previously, he served as President and Chief Executive Officer of St. Joseph Health System from 1995 to 2004.

Statuto currently serves as a member of the boards of directors of the Catholic Medical Mission Board and the Innovation Institute. He previously served as chairman of the board of directors of Catholic Health Association and as vice chairman of the board of directors of Christus Health System.

Statuto received his bachelor’s degree in chemical engineering from Vanderbilt University and his MBA from Xavier University.

Michael J. Alkire is the President and CEO of Premier. As the leader of Premier, Alkire leads the continued integration of Premier’s clinical, financial, supply chain and operational performance improvement offerings helping member hospitals and health systems provide higher quality care at a better cost. He oversees Premier’s quality, safety, labor and supply chain technology apps and data-driven collaboratives allowing alliance members to make decisions based on a combination of healthcare information. These performance improvement offerings access Premier’s comparative database, one of the nation’s largest outcomes databases.

Alkire also led Premier’s efforts to address public health and safety issues from the nationwide drug shortage problem, testifying before the U.S. House of Representatives regarding Premier research on shortages and gray market price gouging. This work contributed to the president and Congress taking action to investigate and correct the problem, resulting in two pieces of bipartisan legislation.

Prior to serving as President and CEO, Alkire was president of Premier Purchasing Partners, which offers group purchasing, supply chain and resource utilization services to hospitals and health systems. Premier remains among the top group purchasing organizations in the industry as the value of supplies purchased through its contracts has increased to more than $56 billion. Upon joining Premier in late 2003, Alkire worked closely with the Purchasing Partners team to develop and implement a three-year transformation plan designed to dramatically increase returns to the alliance’s shareholders while building stronger relationships with members and suppliers.

Alkire is a past board member of GHX and the Healthcare Supply Chain Association. Most recently, he was recognized as one of the 100 Most Influential People in Healthcare in 2021 by Modern Healthcare. In 2018, he was named one of the Top 25 COOs in Healthcare. In 2015, Alkire won the Gold Stevie Award for Executive of the Year and in 2014 he was recognized as a Gold Award Winner for COO of the Year by the Golden Bridge Awards. He has more than 20 years of experience in running business operations and business development organizations at Deloitte & Touche and Cap Gemini Ernst & Young. Before joining Premier, he served in a number of leadership roles at Cap Gemini, including North American responsibilities for supply chain and high-tech manufacturing.

Alkire graduated magna cum laude with a Bachelor of Science from Indiana State University and a MBA from Indiana University.

Helen M. Boudreau has served as a member of the board of directors of Premier since June 2020. She previously served as Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute and held Chief Financial Officer roles at public and private biotech companies.

Over the course of her more than 30-year career, Boudreau held positions of increasing scope and responsibility in finance in the pharmaceutical industry, including roles as Chief Financial Officer for Novartis Corporation in the U.S., global Chief Financial Officer for Novartis Oncology and senior finance positions at Pfizer Inc. Her experience spans multiple industries and functions, and includes roles at Bank of America, McKinsey & Company, PepsiCo, Pfizer and Novartis.

Boudreau currently serves on the board of directors and as chair of the Audit Committee and member of the Compensation Committee of each of Shattuck Labs Inc., a NASDAQ-listed company, and Field Trip Health Ltd., a company listed on the Canadian Securities Exchange. She also serves on the board of directors of a private biotech. She previously served as a board member and Audit Committee chair for NASDAQ-listed Proteostasis Therapeutics Inc.

Boudreau received a bachelor’s degree from the University of Maryland and an MBA from the Darden School at the University of Virginia.